PHAT SG&A Expense Growth
Phathom Pharmaceuticals Inc · SG&A Expense Growth
PHAT SG&A Expense Growth
Latest reported-3.77%period ending
PHAT FY SG&A Growth (YoY) (0.00% → -3.77%)
Latest values, visible window
High-resolution chart · PNG
PHAT sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -3.7662% | |
| 146.4758% | |
| 17.4827% | |
| 61.3266% | |
| 128.6108% | |
| 291.9499% | |
| 476.2656% | |
| 0% |